Association of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease with FADS2 rs3834458 Gene Polymorphism in the Chinese Han Population

Table 1

Comparison of clinical characteristics among the control group, the NAFLD group, and the NAFLD+CAD group.

Indicators	Control	NAFLD	CAD+NAFLD
Cases (male/female)	149 (75/74)	113 (59/54)	75 (38/37)	0.927
Ages (years)				0.442
BMI (kg/m^2)				<0.001
GLU (mmol/L)	4.56 (1.11)	4.84 (0.67)	5.32 (1.43)	<0.001
TBIL (μmol/L)				0.242
ALT (U/L)	17.66 (11.16)	23.62 (21.20)	22.63 (18.03)	<0.001
AST (U/L)	20.71 (6.44)	21.64 (7.44)	20.96 (18.43)	0.141
GGT (U/L)	19.59 (14.54)	32.55 (27.24)	25.15 (16.65)	<0.001
ALP (U/L)				<0.001
TG (mmol/L)	1.11 (0.75)	1.67 (1.17)	1.46 (1.21)	0.031
TC (mmol/L)				<0.001
LDL-C (mmol/L)				<0.001
HDL-C (mmol/L)				<0.001

Control: healthy control; NAFLD: nonalcoholic fatty liver disease; NAFLD+CAD: NAFLD patients with coronary artery disease. The data of normal distribution were expressed as ; the data of nonnormal distribution were expressed as median (interquartile range). BMI: body mass index; GLU: glucose; TBIL: total bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: γ-glutamyl transferase; ALP: alkaline phosphatase; TG: triglyceride; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol.